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Abstract Vestitone reductase and 7,2’-dihydroxy-4’-methoxy-isoflavanol (DMI) dehydratase are the two final enzymes in medicarpin biosynthesis 
in alfalfa (Medicugo sativa). Although two independent enzymes, vestitone reductase and DMI dehydratase can be loosely associated in low ionic 
strength buffers, presumably by a weak protein-protein interaction. The activities of vestitone reductase and DMI dehydratase increased approxi- 
mately 3-fold 6 hours after elicitor treatment in alfalfa suspension cell culture. The activities remained at maximal evels for 40 hours, correlating 
with a steady increase in the medicarpin content of the cells. Medicarpin produced in vitro from vestitone by the action of vestitone reductase and 
DMI dehydratase was found to be (-)-medicarpin (6aR,l laR-medicarpin), possessing the same stereochemistry as medicarpin produced in vivo. 
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1. Introduction 
Attacks by fungal pathogens stimulate the biosynthesis of 
antimicrobial pterocarpan phytoalexins in leguminous plants 
[l]. Medicarpin is the major pterocarpan phytoalexin which 
accumulates in infected alfalfa (Medicago sativa L.) [2], a major 
forage crop in North America and other parts of the world. The 
observation that medicarpin is toxic to several fungal patho- 
gens of alfalfa, along with other correlative evidence, suggests 
that medicarpin biosynthesis plays an important role in the 
defense response of alfalfa [2,3]. 
Several enzymes in the pathway leading to medicarpin and 
other pterocarpans are well characterized; the first six enzymes, 
from phenylalanine ammonia-lyase to chalcone isomerase, 
have been purified and/or cloned from various species, includ- 
ing alfalfa [3,4]. Until recently, isoflavone reductase (IFR) (see 
Fig. 1) was the only pterocarpan- or isoflavonoid-specific en- 
zyme purified or cloned [5]. IFR from alfalfa has been shown 
to stereospecifically reduce 2’-hydroxy-formononetin, a 2’-hy- 
droxylated isoflavone, to (3R)-vestitone, a 2’-hydroxylated 
isoflavanone. It had been reported earlier that the final step in 
medicarpin biosynthesis was the conversion of vestitone to 
medicarpin by a single enzyme, ‘pterocarpan synthase’ (PTS) 
[6,7]. Analogous results were reported for the synthesis of a 
similar pterocarpan in soybean [8]. Like the earlier enzymes in 
the pathway, PTS activity was shown to increase following 
elicitation of plant cell cultures, but only very preliminary puri- 
fication progress was reported [6,8]. 
Recently, we have found that the conversion of vestitone to 
medicarpin is catalyzed by two independent enzymes [9]. The 
first enzyme, vestitone reductase, catalyzes the NADPH-de- 
pendent reduction of vestitone to 7,2’-dihydroxy-4’-methoxy- 
isoflavanol (DMI). The second enzyme, DMI dehydratase, cat- 
alyzes the loss of water and closure of an ether ring to form 
medicarpin (Fig. 1). The exact mechanism of ring closure re- 
mains uncertain; both a carbocation and a quinone methide 
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intermediate have been proposed [lo]. We have purified vesti- 
tone reductase to homogeneity. It appears to be a monomer of 
38 kDa as determined by SDS-PAGE, with strict substrate 
stereo-specificity for (3R)-vestitone with a K,,, value of 45 ,uM. 
The second enzyme, DMI dehydratase, was partially purified. 
It has a native molecular mass of 38 kDa and a K,,, value of 
5 PM for DMI [9], but its product stereo-specificity was not 
determined. Only (-) or (6aR,l laR)-medicarpin accumulates in 
alfalfa cells. 
We report here that vestitone reductase and DMI dehydra- 
tase can form a weak association, probably via protein-protein 
interactions, although they co-elute around the monomer mo- 
lecular weights under normal conditions of gel-filtration (ex- 
plaining the previous conclusions that ‘pterocarpan synthase’ 
was one enzyme). Both activities are rapidly induced, with 
similar kinetics, in elicitor-treated alfalfa cell suspension cul- 
tures. DMI dehydratase produces only (6aR, 1laR)medicarpin 
from 7,2’-dihydroxy-4-methoxy-isoflavanol, consistent with the 
stereochemistry of the medicarpin accumulated in alfalfa and 
the stereochemical outcomes of the preceeding isoflavone re- 
ductase and vestitone reductase reactions. 
2. Materials and methods 
2.1. Plant material 
Callus and suspension cultures of alfalfa were initiated and main- 
tained as described [I 11. Alfalfa suspension cells were treated with yeast 
elicitor and harvested at different times as described [5]. 
2.2. Chemicals 
Vestitone was produced by reducing 2’-hydroxyformononetin using 
NADPH as the reducing agent and the cloned alfalfa isoflavone reduc- 
tase (IFR) expressed in Escherichia coli as the catalyst [5]. This enzy- 
matic reduction initially produces (3R)-vestitone which can gradually 
racemize in solution. Since vestitone reductase can only use (3R)-vesti- 
tone as substrate and is not inhibited by (3S)-vestitone [9], the crude 
vestitone was racemized under basic conditions to stabilize the percent- 
age of useable isomer [12]. Racemic vestitone was purified by semi- 
preparative HPLC [9,12] for use in all assays. 
7,2’-Dihydroxy-4’-methoxy-isoflavanol (DMI) was synthesized from 
large scale vestitone reductase reactions (see below) using purified ves- 
titone reductase from alfalfa [9]. DMI was purified by semi-preparative 
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HPLC, taking care to avoid any contact with acidic solutions. After 
dissolving in methanol, the concentration of DMI was adjusted based 
on the relative absorptivities of DMI and medicarpin at 287 nm, as 
determined by HPLC monitoring of the DMI dehydratase assay (see 
below). 
(-)-Medicarpin (6aR, 1 la&medicarpin) was purified from alfalfa 
roots by semi-preparative HPLC as described previously [13]. (+)- 
Medicarpin (6aS,l la9medicarpin) was extracted from infected peanut 
leaves [14] and purified by the same method used for (-)-medicarpin. 
The identity and stereochemistry of the two forms of medicarpin were 
confirmed by UV, MS, NMR, CD, and HPLC retention time (N. Paiva, 
unpublished results). 
2.3. Extraction and assay of vestitone reductase and DMI dehydratase 
Frozen cells (1 g) were homogenized with 2 ml of 0.2 M Tris-HCl, 
pH 7.5, containing 10% glycerol and 14 mM B-mercaptoethanol. Poly- 
vinylpolypyrrolidone (PVPP; 10% w/w) was then added to the homoge- 
nate and mixed for 10 min. The mixture was then centrifuged at 
27,500 x g for 40 min and the pellet discarded. The supematant was 
used directly for enzyme assays. 
The standard vestitone reductase assay mixture contained 0.2 M 
sodium phosphate buffer, pH 6.0, 1 mM NADPH, 50 ,uM vestitone, 
and enzyme in a total volume of 500 ~1, as described previously [6]. 
Reactions were conducted at 30°C for 15 min and terminated by adding 
1 ml of ethyl acetate. After partitioning, 0.75 ml of organic phase was 
taken to dryness under a stream of N, and redissolved in 150 ~1 of 
methanol; a 20 ,~l aliquot was used for HPLC analysis (System Gold 
Model 126 HPLC system equipped with a Model 168 photodiode array 
detector, Beckman, Fullerton, CA). Compounds were separated on a 
Cl8 column (250 x 4.6 mm, 5pm packing, J.T. Baker, Phillipsburg, NJ) 
using a non-acidic gradient system (80% H,0/20% CH,CN to 40% 
H,0/60% CH,CN in 20 min, 1.5 ml/min) [9]. One unit is defined as the 
amount of enzyme reducing 1 pmol of vestitone per hour. 
The standard DMI dehydratase assay mixture contained 0.2 M so- 
dium phosphate buffer, pH 6.0, 50 PM DMI, and enzyme in a total 
volume of 500 ~1191. Reactions were conducted at 30°C for 5 min. and 
then terminated and assayed by HPLC as described above for the 
vestitone reductase assay, using the non-acidic gradient system. One 
unit is defined as the amount of enzyme synthesizing 1 pmol of medi- 
carpin per hour. 
2.4. Measurement of medicarpin 
Medicarpin and its conjugated form, medicarpin-3-O-glucoside-6”- 
O-malonate (MGM) were extracted from frozen cells using cold ace- 
tone and quantified by HPLC as described previously [15]. ‘Total 
medicarpin is the sum of the values obtained for these two forms of 
medicarpin. 
2.5. Identification of the stereochemistry of medicarpin 
The medicarpin generated by DMI dehydratase or by mild acid 
treatment of DMI was separated by HPLC as described for the enzyme 
assay. The medicarpin peak was collected, extracted three times with 
an equal volume of ethyl acetate, and the organic phases pooled and 
dried. The stereochemistry of medicarpin was then determined by 
chromatography using an analytical-scale chiral HPLC column 
(Chiralpak OT(+), 250 x 4.6 mm, 5 pm packing, with a 50 mm pre- 
column; Daicel Chemical Industries, Ltd., Japan) using isocratic elu- 
tion (100% MeOH, O”C, 0.75 ml/min) [16]. By comparing the elution 
profiles of standard (-)-medicarpin and (+)-medicarpin, it was deter- 
mined that the (+)-medicarpin eluted first (8.3 min) and the (-)-medi- 
carpin second (12.4 min), as previously reported. 
2.6. Gel filtration conditions 
Gel filtration was performed on a FPLC Superdex 75 HR 10130 
column (Pharmacia) with buffers indicated in the text at a flow rate of 
0.5 ml/min at 4°C. Fractions (0.5 ml) were collected and assayed di- 
rectly for vestitone reductase and DMI dehydratase activity. 
3. Results 
3.1. Interaction of vestitone reductase and DMZ dehydratase 
We have shown that the conversion of vestitone to medi- 
carpin is catalyzed by two enzymes, vestitone reductase (34 
kDa, native molecular weight) and DMI dehydratase (38 kDa) 
[9]. Using gel filtration, we tested whether or not these two 
enzymes can interact. Twenty units of purified vestitone reduc- 
tase (0.04 mg protein) were mixed with 100 units of partially 
purified DMI dehydratase (0.06 mg total protein) and chroma- 
tographed over a Superdex 75 FPLC column using 20 mM 
potassium phosphate buffer, pH 7.5, containing 7 mM mercap- 
toethanol, and 100 mM KCl. Fig. 2A shows the elution profile 
of a mixture of molecular weight standards, 66 kDa, 44 kDa, 
17 kDa, and 1.35 kDa. Fig. 2B shows the elution profile of 
vestitone reductase and DMI dehydratase. Vestitone reductase 
eluted at 20.5 min (34 f 2 kDa) and DMI dehydratase at 21 min 
(38 f 2 kDa), as previously observed [9]. However, when we 
omitted the 100 mM KC1 from the chromatography buffer, part 
of the vestitone reductase activity and all of the DMI dehydra- 
tase activity were shifted to 17.5 min (70 f 4 kDa) (Fig. 2C). 
Omitting or including 100 mM KC1 did not change the elution 
times of the molecular weight standards, vestitone reductase 
alone, or DMI dehydratase alone. 
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Fig. 1. The final steps of medicarpin biosynthesis in alfalfa. The 
isoflavanone (3R)-vestitone is reduced by vestitone reductase to 7,2’- 
dihvdroxv-4’-methoxv-isoflavanol (DMI). DMI dehvdratase catalyzes 
the-loss of H,O and hng closure to the final pterocarpan, via either a 
carbocation (a) or quinone methide (b) intermediate. The names of the 
enzymes are abbreviated as follows: IFR, isoflavone reductase; VR, 
vestitone reductase; DMID, DMI dehydratase. 
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3.2. Elicitation of vestitone reductase and DMI dehydratase in 
alfalfa suspension cell culture 
Fig. 3 shows the changes in the activities of vestitone reduc- 
tase and DMI dehydratase, as well as total medicarpin accumu- 
lation, in alfalfa suspension cell cultures following treatment 
with an elicitor preparation derived from yeast. The induction 
of vestitone reductase (Fig. 3A) and DMI dehydratase (Fig. 3B) 
followed the same pattern. The activities rapidly increased 
about 3-fold, with near maximal activities being reached within 
6 to 8 h and the activities remaining high throughout the 48 h 
time course. Total medicarpin levels (free medicarpin and the 
malonylated glucoside of medicarpin (MGM)) also increased 
steadily after these enzyme levels increased (Fig. 3C), as re- 
ported previously [S]. 
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Fig. 2. Effect of salt concentration  the elution of vestitone reductase 
and DMI dehydratase during gel filtration on an FPLC Superdex 75 
column. (A) A mixture of molecular weight standards: BSA, 66 kDa; 
ovalbumin (chicken), 44 kDa; myoglobin (horse), 17 kDa; and vitamin 
B-12, 1.35 kDa. (B) Mixture of purified vestitone reductase (20 units, 
0.04 mg total protein) and partially purified DMI dehydratase (100 
units, 0.06 mg total protein). The vestitone reductase activity (0) and 
DMI dehydratase activity (0) in collected fractions are indicated. The 
chromatography buffer was 20 mM potassium phosphate buffer, pH 
7.5, containing 7 mM B-mercaptoethanol and 100 mM KCl. (C) Same 
protein mixtures and elution conditions as in (B), except hat KC1 was 
omitted from the chromatography buffer. 
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Fig. 3. Changes in activities of vestitone reductase (A) and DMI dehy- 
dratase (B) and total medicarpin levels (C) in alfalfa suspension cell 
cultures in response to fungal elicitor treatment (0) or in unelicited 
controls (0). Filter-sterilized elicitor was added to the cultures four days 
after subculture, and then samples were collected at the times indicated. 
3.3. Stereochemistry of medicarpin produced by the action of 
vestitone reductase and Dh4I dehydratase 
It has been reported that infected alfalfa leaves and elicited 
cell cultures only accumulate (-)- or (6aR,l laR)-medicarpin 
[l, 131. Isoflavone reductase creates the first chiral center by 
reducing an achiral substrate to (3R)-vestitone (the C3 of vesti- 
tone corresponds to C6a of medicarpin; see Fig. 1) [S]. We have 
recently shown that vestitone reductase will only accept (3R)- 
vestitone as its substrate; (3S)-vestitone neither serves as a 
substrate, nor does it inhibit the reaction [9]. The stereochemis- 
try of the in vitro product of DMI dehydratase has not yet been 
investigated. It is also possible to convert DMI to medicarpin 
by non-enzymatic means. Heating DMI in the presence of acid 
will cause dehydration and ring closure [9], but the stereochem- 
istry of the product of this reaction has not been determined 
previously. 
DMI was synthesized by reducing vestitone with vestitone 
reductase and then purified by HPLC. A portion of the DMI 
was then reacted with DMI dehydratase and the in vitro, enzy- 
matically produced medicarpin was purified. Similarly, another 
portion of the DMI was treated with HCl(O.1 M HCl, 15 min, 
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Fig. 4. Determination of the stereochemistry of the in vitro product 
medicarpin by chiral HPLC column chromatography. (A) Medicarpin 
produced from the in vitro reduction of vestitone by vestitone reductase 
to produce DMI, followed by ring closure catalyzed by DMI dehydra- 
tase. (B) Medicarpin produced as in (A), except ring closure was cata- 
lyzed by heating with acid. (C) (-)-Medicarpin standard, (D) (+)-Medi- 
carpin standard. Peaks assigned to (+) or (-) medicarpin are labeled 
with a (+) or (-) symbol. Other peaks in the chromatograms donot 
have the UV spectrum of medicarpin, and are due to solvent effects or 
impurities. 
30°C) and the resulting medicarpin was purified. The stereo- 
chemistry of each preparation of medicarpin was then deter- 
mined by chromatography using a chiral HPLC column. The 
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medicarpin produced by the in vitro DMI dehydratase reaction 
and by the acid-catalyzed ehydration had identical retention 
times on the chiral column (Fig. 4A and B). This retention time 
(12.4 min) matched that of (6aR,l laR)-medicarpin (Fig. 4C); 
no trace of (6aS,llaS)-medicarpin (Fig. 4D) was observed. 
4. Discussion 
The gel filtration results indicate that although vestitone re- 
ductase and DMI dehydratase are two independent enzymes, 
they can bind together by a weak protein-protein interaction. 
This weak interaction can be disrupted by 100 mM KCl. Judg- 
ing by the molecular weight shift, the complex formed between 
vestitone reductase and DMI dehydratase probably contains 
one molecule of each enzyme. The incomplete shift of vestitone 
reductase activity was due to the presence of a molar excess of 
vestitone reductase. Presumably, the close association of vesti- 
tone reductase and DMI dehydratase in vivo would facilitate 
the synthesis of medicarpin by minimizing the need for diffu- 
sion of the DMI intermediate. A similar weak protein-protein 
interaction has been proposed between chalcone reductase 
(CHR) and chalcone synthase (CHS), two enzymes earlier in 
the pathway [17,18], and high salt concentrations also inhibited 
the interaction of CHR and CHS [17]. Also, several authors 
have presented both experimental evidence and theoretical ar- 
guments suggesting that many of the flavonoid biosynthetic 
enzymes are arranged sequentially in a large complex, loosely 
associated with the cytosolic side of the membrane of the endo- 
plasmic reticulum or other organelle [19,20]. The structural 
basis for the protein-protein interaction between vestitone re- 
ductase and DMI dehydratase will be investigated using molec- 
ular modelling following the cloning and sequencing of these 
two genes. 
Medicarpin is rapidly accumulated in alfalfa suspension cell 
cultures following addition of yeast elicitor. The activities of 
early pathway enzymes common to both phenylpropanoid and 
flavonoid metabolism, such as phenylalanine ammonia-lyase, 
cinnamic acid 4-hydroxylase, chalcone synthase and chalcone 
isomerase, are rapidly but transiently increased (2- to 30-fold 
within 10 to 15 h) [3,21]. In contrast, the pterocarpan-specific 
isoflavone reductase showed an equally rapid increase in en- 
zyme activity (- lo-fold in 12 h) but remained at high levels until 
more than 48 h post-elicitation, long after the activities of early 
enzymes had returned to control levels [5]. Here we report that 
the activities of vestitone reductase and DMI dehydratase, the 
two final enzymes in the pathway, both increased 3- to 4-fold 
within 8 h of elicitation. Both activities remained high through- 
out the remainder of the 48-hour time course, yielding a pattern 
much more similar to that of isoflavone reductase than to the 
early pathway enzymes. This level of increase is in agreement 
with the 2- to 3-fold increase previously observed in alfalfa cells 
for ‘pterocarpan synthase’ [S], which represents the total con- 
version from vestitone to medicarpin; similar results were ob- 
tained in soybean [6] and chickpea [8] cultures for analogous 
‘pterocarpan synthase’ activities. The higher levels of late path- 
way enzymes correlates well with the continued increase in the 
medicarpin content of the elicited cultures. 
Analysis by chiral HPLC chromatography indicates that 
only (-)- or (6aR,l laR)-medicarpin is produced by either acid- 
catalyzed dehydration or the action of DMI dehydratase in 
vitro on enzymatically produced DMI. This is consistent with 
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reports that alfalfa plants and cell cultures only accumulate 
(6aR, 1 laR)-medicarpin in vivo. Isoflavone reductase produces 
(3R)-vestitone, which is in turn the only isomer of vestitone 
utilized by vestitone reductase [5,9]. The stereochemistry of the 
6a carbon is presumably fixed by the stereospecificity of vesti- 
tone reductase; once the keto group in vestitone is reduced, it 
is difficult chemically to invert the stereochemistry at the 3R 
position of DMI. Whether the subsequent dehydration and ring 
closure proceeds via a cationic or quinone methide transition 
state, the carbon corresponding to lla becomes achiral (Fig. 
1). We believe that the configuration of the second chiral center 
(1laR) is determined by the configuration of the first (6aR). The 
R contiguration at the 6a carbon puts the aromatic hydroxyl 
above the plane of the rest of the molecule, and the new C-0 
bond must form on this side, to avoid undue ring strain. The 
stereochemistry of the pterocarpan system can be extremely 
important in determining the antifungal activity against certain 
pathogens ([22]; J. Blount, R.A. Dixon, H.D. VanEtten and N. 
Paiva, unpublished results). Efforts are underway to determine 
how legumes which synthesize (+) and (-) pterocarpans differ 
in the final steps of the pathway; preliminary results indicate 
that the vestitone reductase substrate stereo-specificities are 
reversed (N. Paiva, unpublished results). 
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